Cargando…
A Randomized Clinical Trial Testing Hydroxychloroquine for Reduction of SARS-CoV-2 Viral Shedding and Hospitalization in Early Outpatient COVID-19 Infection
Early in the COVID-19 pandemic, no effective treatment existed to prevent clinical worsening of COVID-19 among recently diagnosed outpatients. At the University of Utah, Salt Lake City, Utah, we conducted a phase 2 prospective parallel group randomized placebo-controlled trial (NCT04342169) to deter...
Autores principales: | Spivak, Adam M., Barney, Bradley J., Greene, Tom, Holubkov, Richard, Olsen, Cody S., Bridges, Jordan, Srivastava, Raj, Webb, Brandon, Sebahar, Frances, Huffman, Ainsley, Pacchia, Christina F., Dean, J. Michael, Hess, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101001/ https://www.ncbi.nlm.nih.gov/pubmed/36861976 http://dx.doi.org/10.1128/spectrum.04674-22 |
Ejemplares similares
-
Hydroxychloroquine versus Azithromycin for Hospitalized Patients with
Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label,
Active Comparator Trial
por: Brown, Samuel M., et al.
Publicado: (2020) -
SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021) -
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19
por: Lofgren, Sarah M, et al.
Publicado: (2020) -
Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
por: Harrigan, James J., et al.
Publicado: (2020) -
Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study
por: Ip, Andrew, et al.
Publicado: (2021)